Target intelligence / Profile preview

Macrophage-1 antigen (integrin alpha-M beta-2) (Mac-1)

Target
Mac-1
Molecular classification
Receptor, Integrin, Pattern recognition receptor (PRR), β2-integrin
01

Overview

Mac-1 receptor (Macrophage-1 antigen, integrin alpha-M beta-2, CD11b/CD18, complement receptor 3) is a broadly expressed integrin and pattern recognition receptor on myeloid and lymphoid cells. It mediates cell adhesion, migration, phagocytosis, and recognition of opsonized pathogens via interactions with iC3b, ICAM-1, and numerous extracellular ligands. Mac-1 plays central roles in the innate immune response, inflammation, tissue regeneration, and thrombosis. Therapeutically, Mac-1 blockade is being explored for inflammatory and autoimmune indications, but targeting strategies must balance immune suppression with preservation of essential host defense and regenerative functions.

Other names
Complement receptor 3 (CR3)Integrin alpha-M beta-2CD11b/CD18Macrophage integrin
02

Mechanism of action

Ligand-blocking antibodies interrupt adhesion and migration (leukocyte recruitment, inflammation); Inhibition suppresses binding to iC3b, CD40L, and other ligands, reducing immune cell activation and migration; Modulation of phagocytosis and cytokine release.

03

Biological functions

Cell adhesionLeukocyte migration/transmigrationPhagocytosisChemotaxisInnate immune responseCellular activationCytotoxicityRecognition of DAMPs (damage-associated molecular patterns) and PAMPs (pathogen-associated molecular patterns)
04

Disease associations

InflammationAtherosclerosisAutoimmune diseaseInfection (bacterial, viral)Arthritis/myositisIschemic kidney injuryGlomerulonephritis
05

Safety considerations

Inhibition of Mac-1 may impair host defense, wound healing, and thrombosis regulationPotential risk of increased infection or reduced immune competence
06

Interacting drugs

Monoclonal antibodies targeting Mac-1 (experimental/therapeutic research)

2 more in the full profile.

07

Biomarkers

CD11b/CD18 expression on leukocytesUpregulation in activated neutrophils and inflammation

Beyond the preview

Go deeper on Macrophage-1 antigen (integrin alpha-M beta-2) (Mac-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage-1 antigen (integrin alpha-M beta-2) (Mac-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call